2413-54-9 Usage
Uses
Used in Research Applications:
1-(4-Fluorophenyl)-2-methyl-2-aminopropane hydrochloride is used as a research chemical for studying the effects of psychoactive substances on the central nervous system. Its ability to release neurotransmitters like serotonin, dopamine, and norepinephrine makes it a valuable tool for understanding the mechanisms of action of stimulant drugs.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 4-FA may be used as a starting point for the development of new medications targeting conditions such as ADHD, depression, and other disorders that could benefit from stimulant effects. Its unique profile of neurotransmitter release offers potential for the creation of more targeted and safer therapeutic agents.
Used in Forensic Toxicology:
1-(4-Fluorophenyl)-2-methyl-2-aminopropane hydrochloride is utilized in forensic toxicology for the identification and analysis of controlled substances in biological samples. Its presence in samples can indicate the use of designer drugs or other illicit substances, aiding in the investigation of drug-related crimes and overdose cases.
Check Digit Verification of cas no
The CAS Registry Mumber 2413-54-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,4,1 and 3 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2413-54:
(6*2)+(5*4)+(4*1)+(3*3)+(2*5)+(1*4)=59
59 % 10 = 9
So 2413-54-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H14FN.ClH/c1-10(2,12)7-8-3-5-9(11)6-4-8;/h3-6H,7,12H2,1-2H3;1H
2413-54-9Relevant academic research and scientific papers
METHODS FOR PREPARING GLUTAMIC ACID DERIVATIVES AND INTERMEDIATES THEREOF
-
Page/Page column 47-48, (2008/06/13)
The present invention relates to novel methods for the preparation of glutamic acid derivatives and intermediates thereof, and such compounds prepared by the novel methods.
Substituted silyl alkylene amines
-
, (2008/06/13)
This invention relates to substituted silyl alkylene amines, to the intermediates and processes useful for their preparation, to their pharmacological use as MAO-B inhibitors and to their end-use application in the treatment of Parkinson's Disease and senile dementia of Alzheimer's type.
